LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Collaboration to Develop NMR Hypersense Technology

By Biotechdaily staff writers
Posted on 17 Oct 2005
Oxford Instruments Molecular Biotools (OIMBL, Oxon, UK) has entered into three landmark collaborative agreements with Pfizer Global R&D (Sandwich, UK), Queen Mary and Westfield College, University of London (London, UK), and the University of Birmingham Institute for Cancer Studies (UK). These agreements allow for the development of sophisticated and innovative applications in nuclear magnetic resonance (NMR) technology, utilizing the dramatic enhancement in the signal-to-noise ratio provided by HyperSense.

HyperSense is a novel in vitro dynamic nuclear polarization (DNP) polarizer capable of amplifying the baseline signal-to-noise ratio of NMR systems by a factor of up to 10,000 for 1D NMR spectral analysis. HyperSense is the first commercial product of its kind that enables scientists to attain an excellent level of information quality and richness, while opening up the field of practical NMR analysis to totally new areas of research. It is a modular instrument that will attach to any traditional NMR system, to deliver polarization-enhanced samples using a solid-state dynamic nuclear polarization (DNP) technique recently licensed from GE Healthcare (Waukesha, WI, USA).

The collaborators, representing some of the major NMR groups across academia and industry in the United Kingdom, will evaluate different aspects of the use of the enhanced levels of signal-to-noise ratio provided by HyperSense, in applications across life science research, pharmaceuticals, and chemistry.

At the biomolecular NMR spectroscopy laboratory at the University of Birmingham, Prof. Michael Overduin and Dr. Ulrich Günther of the CRC Institute for Cancer Studies (Birmingham, UK) will use HyperSense to conduct additional studies to identify biologic markers for different types of cancer and to develop new methods for determining the kinetics and dynamics of protein-ligand interactions.

The diversity of NMR research applications directly reflects the flexibility of applications for HyperSense. By providing the information richness of NMR and enhancing the signal-to-noise ratio by up to 10,000 fold, this technique avoids time-consuming and labor-intensive enrichment processes that were once a requisite.


Related Links:
Oxford Instruments Molecular Biotools
Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Laboratory Software
ArtelWare

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more